Lotus Eye Hospital and Institute Limited Share Price Bombay S.E.

Equities

LOTUSEYE

INE947I01017

Healthcare Facilities & Services

Market Closed - Bombay S.E. 11:00:50 26/04/2024 BST 5-day change 1st Jan Change
61 INR +1.70% Intraday chart for Lotus Eye Hospital and Institute Limited +0.83% -26.81%

Financials

Sales 2022 389M 4.67M 374M Sales 2023 470M 5.64M 452M Capitalization 1.22B 14.62M 1.17B
Net income 2022 29M 348K 27.84M Net income 2023 40M 480K 38.41M EV / Sales 2022 2.64 x
Net cash position 2022 75.55M 906K 72.54M Net cash position 2023 76.6M 919K 73.55M EV / Sales 2023 2.43 x
P/E ratio 2022
36.9 x
P/E ratio 2023
29.9 x
Employees 313
Yield 2022
0.94%
Yield 2023
0.85%
Free-Float 55.24%
More Fundamentals * Assessed data
Dynamic Chart
1 day+1.70%
1 week+0.83%
Current month+7.96%
1 month+5.06%
3 months-23.78%
6 months-23.15%
Current year-26.81%
More quotes
1 week
58.50
Extreme 58.5
62.97
1 month
56.01
Extreme 56.01
64.20
Current year
44.10
Extreme 44.1
95.00
1 year
44.10
Extreme 44.1
110.90
3 years
38.65
Extreme 38.65
110.90
5 years
16.05
Extreme 16.05
110.90
10 years
5.57
Extreme 5.57
110.90
More quotes
Managers TitleAgeSince
Chief Executive Officer 74 30/07/20
Director of Finance/CFO 66 24/05/22
Compliance Officer - 14/02/22
Members of the board TitleAgeSince
Director/Board Member 85 15/10/07
Director/Board Member 75 15/10/07
Director/Board Member 47 31/07/09
More insiders
Date Price Change Volume
26/04/24 61 +1.70% 10,952
25/04/24 59.98 -2.63% 8,637
24/04/24 61.6 +4.07% 2,449
23/04/24 59.19 -1.19% 1,154
22/04/24 59.9 -0.99% 1,009

Delayed Quote Bombay S.E., April 26, 2024 at 11:00 am

More quotes
Lotus Eye Hospital and Institute Limited is an India-based company, which is engaged in the business of healthcare activities. The Company operates primarily in the field of ophthalmology (Eye) and its related operations. It resolves a range of eye problems, such as refractive, cataract, cornea infections, ocular prosthesis, orbit and oculoplasty, glaucoma, keratoconus, computer vision syndrome, neuro ophthalmology, retinal disease/diabetic eye care, UVEA and ocular inflammation, zyoptix-ultimate, and binocular vision. The Company provides treatments through ReLEx SMILE, Lasik Eye Surgery, Epi-LASIK, Intralase, Supracor, Robotic Femto Laser Cataract Surgery (LRCS), Phacoemulsification, Paediatric Eye Care and Squint Surgery, and Micro Incision Cataract Surgery (MICS). The Company operates approximately seven centers at Peelamedu, R.S. Puram, Mettupalayam, Tirupur, Salem, Cochin, and Mulanthurthy.
More about the company